FDA accepts Indevus' Nebido NDA

FDA accepted for review IDEV's NDA for Nebido testosterone depot to treat male hypogonadism. The PDUFA date is June 27, 2008. IDEV received U.S. rights to Nebido from Schering, now part of Bayer (FSE:...